nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—FAAH—forebrain—attention deficit hyperactivity disorder	0.019	0.0526	CbGeAlD
Propofol—FAAH—midbrain—attention deficit hyperactivity disorder	0.0125	0.0348	CbGeAlD
Propofol—SCN2A—forebrain—attention deficit hyperactivity disorder	0.0109	0.0303	CbGeAlD
Propofol—FAAH—nervous system—attention deficit hyperactivity disorder	0.0103	0.0286	CbGeAlD
Propofol—FAAH—central nervous system—attention deficit hyperactivity disorder	0.00993	0.0275	CbGeAlD
Propofol—FAAH—cerebellum—attention deficit hyperactivity disorder	0.00971	0.0269	CbGeAlD
Propofol—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00928	0.0257	CbGeAlD
Propofol—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00928	0.0257	CbGeAlD
Propofol—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00848	0.0235	CbGeAlD
Propofol—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00819	0.0227	CbGeAlD
Propofol—FAAH—brain—attention deficit hyperactivity disorder	0.00789	0.0218	CbGeAlD
Propofol—SCN2A—midbrain—attention deficit hyperactivity disorder	0.00721	0.02	CbGeAlD
Propofol—GABRB3—forebrain—attention deficit hyperactivity disorder	0.00713	0.0197	CbGeAlD
Propofol—SCN4A—nervous system—attention deficit hyperactivity disorder	0.0067	0.0186	CbGeAlD
Propofol—SCN4A—central nervous system—attention deficit hyperactivity disorder	0.00645	0.0179	CbGeAlD
Propofol—GABRB2—midbrain—attention deficit hyperactivity disorder	0.00613	0.017	CbGeAlD
Propofol—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00613	0.017	CbGeAlD
Propofol—CYP1B1—cardiovascular system—attention deficit hyperactivity disorder	0.00595	0.0165	CbGeAlD
Propofol—SCN2A—nervous system—attention deficit hyperactivity disorder	0.00593	0.0164	CbGeAlD
Propofol—SCN2A—central nervous system—attention deficit hyperactivity disorder	0.00571	0.0158	CbGeAlD
Propofol—SCN2A—cerebellum—attention deficit hyperactivity disorder	0.00558	0.0155	CbGeAlD
Propofol—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00541	0.015	CbGeAlD
Propofol—SCN4A—brain—attention deficit hyperactivity disorder	0.00512	0.0142	CbGeAlD
Propofol—GABRB2—nervous system—attention deficit hyperactivity disorder	0.00504	0.014	CbGeAlD
Propofol—GABRG2—nervous system—attention deficit hyperactivity disorder	0.00504	0.014	CbGeAlD
Propofol—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.0049	0.0136	CbGeAlD
Propofol—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.00485	0.0134	CbGeAlD
Propofol—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00485	0.0134	CbGeAlD
Propofol—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.00474	0.0131	CbGeAlD
Propofol—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.00474	0.0131	CbGeAlD
Propofol—GABRB3—midbrain—attention deficit hyperactivity disorder	0.00471	0.013	CbGeAlD
Propofol—GABRA2—nervous system—attention deficit hyperactivity disorder	0.0046	0.0127	CbGeAlD
Propofol—SCN2A—brain—attention deficit hyperactivity disorder	0.00453	0.0126	CbGeAlD
Propofol—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00445	0.0123	CbGeAlD
Propofol—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00443	0.0123	CbGeAlD
Propofol—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00433	0.012	CbGeAlD
Propofol—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00428	0.0119	CbGeAlD
Propofol—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00419	0.0116	CbGeAlD
Propofol—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00409	0.0113	CbGeAlD
Propofol—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00405	0.0112	CbGeAlD
Propofol—CYP2A6—brain—attention deficit hyperactivity disorder	0.00398	0.011	CbGeAlD
Propofol—GABRB3—nervous system—attention deficit hyperactivity disorder	0.00387	0.0107	CbGeAlD
Propofol—GABRB2—brain—attention deficit hyperactivity disorder	0.00385	0.0107	CbGeAlD
Propofol—GABRG2—brain—attention deficit hyperactivity disorder	0.00385	0.0107	CbGeAlD
Propofol—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00383	0.0106	CbGeAlD
Propofol—CYP1B1—nervous system—attention deficit hyperactivity disorder	0.00382	0.0106	CbGeAlD
Propofol—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.00372	0.0103	CbGeAlD
Propofol—CYP1B1—central nervous system—attention deficit hyperactivity disorder	0.00368	0.0102	CbGeAlD
Propofol—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.00364	0.0101	CbGeAlD
Propofol—CYP1B1—cerebellum—attention deficit hyperactivity disorder	0.00359	0.00995	CbGeAlD
Propofol—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00359	0.00994	CbGeAlD
Propofol—GABRA2—brain—attention deficit hyperactivity disorder	0.00352	0.00974	CbGeAlD
Propofol—GABRA1—brain—attention deficit hyperactivity disorder	0.0034	0.00942	CbGeAlD
Propofol—ALB—brain—attention deficit hyperactivity disorder	0.00318	0.00881	CbGeAlD
Propofol—GABRB3—brain—attention deficit hyperactivity disorder	0.00296	0.00819	CbGeAlD
Propofol—CYP1B1—brain—attention deficit hyperactivity disorder	0.00292	0.00808	CbGeAlD
Propofol—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.0027	0.00748	CbGeAlD
Propofol—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00262	0.00726	CbGeAlD
Propofol—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.0026	0.0072	CbGeAlD
Propofol—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00253	0.00699	CbGeAlD
Propofol—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00246	0.00682	CbGeAlD
Propofol—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00237	0.00656	CbGeAlD
Propofol—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00232	0.00642	CbGeAlD
Propofol—CYP2C8—brain—attention deficit hyperactivity disorder	0.00223	0.00619	CbGeAlD
Propofol—CYP1A1—brain—attention deficit hyperactivity disorder	0.00206	0.00571	CbGeAlD
Propofol—CYP2B6—brain—attention deficit hyperactivity disorder	0.002	0.00555	CbGeAlD
Propofol—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00198	0.00549	CbGeAlD
Propofol—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00195	0.0054	CbGeAlD
Propofol—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00191	0.00528	CbGeAlD
Propofol—CYP2E1—brain—attention deficit hyperactivity disorder	0.00188	0.00521	CbGeAlD
Propofol—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00188	0.0052	CbGeAlD
Propofol—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00183	0.00508	CbGeAlD
Propofol—CYP2D6—brain—attention deficit hyperactivity disorder	0.00149	0.00413	CbGeAlD
Propofol—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000745	0.00117	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000731	0.00114	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000717	0.00112	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00071	0.00111	CbGpPWpGaD
Propofol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000707	0.00111	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000705	0.0011	CbGpPWpGaD
Propofol—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000701	0.0011	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000701	0.0011	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000698	0.00109	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00068	0.00106	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000675	0.00106	CbGpPWpGaD
Propofol—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000675	0.00106	CbGpPWpGaD
Propofol—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00067	0.00105	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000639	0.001	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000638	0.000998	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000633	0.000991	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000633	0.000991	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000629	0.000984	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000622	0.000973	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000619	0.000969	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000619	0.000969	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000618	0.000966	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000611	0.000955	CbGpPWpGaD
Propofol—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000599	0.000938	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000581	0.00091	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000565	0.000885	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000557	0.000872	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000557	0.000872	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000548	0.000858	CbGpPWpGaD
Propofol—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000548	0.000857	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000544	0.000852	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000544	0.000851	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000541	0.000846	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00054	0.000845	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000539	0.000844	CbGpPWpGaD
Propofol—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000537	0.00084	CbGpPWpGaD
Propofol—UGT1A9—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000537	0.00084	CbGpPWpGaD
Propofol—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000533	0.000834	CbGpPWpGaD
Propofol—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000529	0.000829	CbGpPWpGaD
Propofol—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000526	0.000823	CbGpPWpGaD
Propofol—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000525	0.000822	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00051	0.000797	CbGpPWpGaD
Propofol—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000503	0.000787	CbGpPWpGaD
Propofol—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000499	0.000781	CbGpPWpGaD
Propofol—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000496	0.000776	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000471	0.000737	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000463	0.000724	CbGpPWpGaD
Propofol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000462	0.000724	CbGpPWpGaD
Propofol—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000462	0.000723	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000461	0.000721	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000459	0.000719	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000458	0.000716	CbGpPWpGaD
Propofol—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000455	0.000711	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000453	0.000709	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000445	0.000697	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00043	0.000673	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000424	0.000664	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000411	0.000644	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000408	0.000639	CbGpPWpGaD
Propofol—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000406	0.000635	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000403	0.000631	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.0004	0.000627	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000395	0.000618	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000395	0.000618	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000393	0.000615	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000387	0.000606	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000378	0.000592	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000376	0.000588	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000375	0.000587	CbGpPWpGaD
Propofol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000373	0.000584	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000372	0.000583	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000371	0.000581	CbGpPWpGaD
Propofol—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00037	0.000579	CbGpPWpGaD
Propofol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000362	0.000566	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000358	0.00056	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000358	0.00056	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000344	0.000538	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000338	0.000528	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000335	0.000525	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000334	0.000522	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00033	0.000517	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00033	0.000517	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000321	0.000502	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000318	0.000498	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000316	0.000495	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000313	0.000489	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000313	0.000489	CbGpPWpGaD
Propofol—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000308	0.000482	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000307	0.000481	CbGpPWpGaD
Propofol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000302	0.000472	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000286	0.000447	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000276	0.000432	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00025	0.000391	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000247	0.000387	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000247	0.000387	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000247	0.000387	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000247	0.000387	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000247	0.000387	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000246	0.000384	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000244	0.000382	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000243	0.00038	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000243	0.00038	CbGpPWpGaD
Propofol—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000243	0.00038	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000238	0.000372	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00023	0.000361	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00023	0.000361	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000227	0.000355	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000226	0.000354	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000226	0.000354	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000223	0.000348	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000218	0.000341	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000211	0.00033	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000208	0.000325	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000206	0.000322	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—EP300—attention deficit hyperactivity disorder	0.000198	0.000311	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000198	0.000309	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000198	0.000309	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000197	0.000308	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00019	0.000298	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00019	0.000298	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—COMT—attention deficit hyperactivity disorder	0.000189	0.000296	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000188	0.000295	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000188	0.000294	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000188	0.000294	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000188	0.000294	CbGpPWpGaD
Propofol—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000187	0.000293	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000187	0.000293	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000184	0.000288	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000175	0.000274	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000174	0.000273	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000168	0.000263	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000155	0.000242	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000154	0.00024	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000154	0.00024	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000153	0.00024	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000152	0.000238	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000151	0.000237	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000151	0.000236	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000151	0.000236	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00015	0.000234	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—COMT—attention deficit hyperactivity disorder	0.00015	0.000234	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000149	0.000233	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000149	0.000233	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000148	0.000232	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000227	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000145	0.000227	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000144	0.000226	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000142	0.000222	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000142	0.000222	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000141	0.00022	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00014	0.000218	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00014	0.000218	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000139	0.000217	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000138	0.000215	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000134	0.00021	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000131	0.000205	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00013	0.000204	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00013	0.000204	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00013	0.000203	CbGpPWpGaD
Propofol—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000129	0.000202	CbGpPWpGaD
Propofol—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000129	0.000202	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000128	0.0002	CbGpPWpGaD
Propofol—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000127	0.000199	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000123	0.000192	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00012	0.000188	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000119	0.000186	CbGpPWpGaD
Propofol—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000118	0.000185	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000117	0.000183	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000116	0.000182	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000116	0.000182	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000115	0.000181	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000115	0.000179	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000115	0.000179	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000114	0.000179	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000113	0.000178	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000108	0.000169	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000107	0.000167	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000107	0.000167	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000106	0.000166	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000106	0.000166	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000106	0.000166	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000105	0.000164	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000104	0.000163	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000104	0.000163	CbGpPWpGaD
Propofol—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000103	0.000162	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000101	0.000158	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.9e-05	0.000155	CbGpPWpGaD
Propofol—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.84e-05	0.000154	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.77e-05	0.000153	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.68e-05	0.000152	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	9.31e-05	0.000146	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.28e-05	0.000145	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.24e-05	0.000145	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	9.12e-05	0.000143	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.05e-05	0.000142	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	9.05e-05	0.000142	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.05e-05	0.000142	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	8.9e-05	0.000139	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.84e-05	0.000138	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.6e-05	0.000135	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.54e-05	0.000134	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.54e-05	0.000134	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.46e-05	0.000132	CbGpPWpGaD
Propofol—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	8.29e-05	0.00013	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.28e-05	0.00013	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.27e-05	0.00013	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.13e-05	0.000127	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—EP300—attention deficit hyperactivity disorder	8.12e-05	0.000127	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.06e-05	0.000126	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	7.88e-05	0.000123	CbGpPWpGaD
Propofol—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	7.84e-05	0.000123	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	7.83e-05	0.000122	CbGpPWpGaD
Propofol—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	7.78e-05	0.000122	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.59e-05	0.000119	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.55e-05	0.000118	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.23e-05	0.000113	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	7.03e-05	0.00011	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	6.99e-05	0.000109	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.98e-05	0.000109	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	6.98e-05	0.000109	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.89e-05	0.000108	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	6.87e-05	0.000108	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.77e-05	0.000106	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	6.47e-05	0.000101	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.42e-05	0.000101	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	6.42e-05	0.0001	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—EP300—attention deficit hyperactivity disorder	6.42e-05	0.0001	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	6.41e-05	0.0001	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.39e-05	9.99e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	6.37e-05	9.97e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.18e-05	9.67e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—EP300—attention deficit hyperactivity disorder	5.99e-05	9.37e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.58e-05	8.74e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	5.48e-05	8.58e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	5.44e-05	8.52e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.31e-05	8.32e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.28e-05	8.26e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	4.95e-05	7.74e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.23e-05	6.62e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.2e-05	6.57e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	3.99e-05	6.25e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.91e-05	6.12e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.69e-05	5.77e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	3.38e-05	5.29e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	3.36e-05	5.26e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	3.02e-05	4.72e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.77e-05	4.34e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.75e-05	4.31e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.35e-05	3.68e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.81e-05	2.84e-05	CbGpPWpGaD
